Correlation Between 23Andme Holding and Lumos Pharma
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Lumos Pharma, you can compare the effects of market volatilities on 23Andme Holding and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Lumos Pharma.
Diversification Opportunities for 23Andme Holding and Lumos Pharma
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between 23Andme and Lumos is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Lumos Pharma go up and down completely randomly.
Pair Corralation between 23Andme Holding and Lumos Pharma
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Lumos Pharma. In addition to that, 23Andme Holding is 7.45 times more volatile than Lumos Pharma. It trades about -0.2 of its total potential returns per unit of risk. Lumos Pharma is currently generating about -0.04 per unit of volatility. If you would invest 436.00 in Lumos Pharma on August 24, 2024 and sell it today you would lose (5.00) from holding Lumos Pharma or give up 1.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Lumos Pharma
Performance |
| Timeline |
| 23Andme Holding |
| Lumos Pharma |
23Andme Holding and Lumos Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Lumos Pharma
The main advantage of trading using opposite 23Andme Holding and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Eliem Therapeutics | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |